|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38 EUR | +0.54% |
|
+3.74% | +0.08% |
| 09:02am | FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies | ZD |
| Apr. 24 | European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading | MT |
(Reuters) - German dialysis specialist Fresenius Medical Care on Wednesday posted a lower-than-expected net income for the first quarter, weighed down by high coronavirus-related deaths among its patients and elevated labour costs in the U.S.
The quarterly net income of the world's largest provider of dialysis treatments dropped 37% to 157 million euros ($165.09 million), against 159 million euros expected by analysts polled by Vara Research.
The group maintained its earlier forecast for revenue and net income growth at low- to mid-single-digit percentage rates in 2022.
($1 = 0.9510 euros)
(Reporting by Milla Nissi and Jagoda Darlak in Gdansk; editing by Uttaresh.V)
| 1st Jan change | Capi. | |
|---|---|---|
| +0.08% | 11.88B | |
| -14.73% | 84.87B | |
| +16.05% | 83.08B | |
| +10.92% | 29.4B | |
| -12.73% | 16.72B | |
| -3.85% | 16.4B | |
| -1.78% | 15.04B | |
| -31.40% | 11.86B | |
| -5.12% | 11.88B | |
| +26.74% | 11.64B |
FRESENIUS MEDICAL CARE AG 
